RSV Vaccine Abrysvo Approved for Individuals 60 Years and Older
Abrysvo is expected to be available in the third quarter of 2023.
Diagnosis & Disease Information
US COVID-19 Hospitalizations Reach Record Low
Hospitalizations are among the few COVID-19 metrics still being monitored by public health officials.
Paxlovid Receives FDA Approval for COVID-19 Treatment
The is the first approval of an oral antiviral therapy for COVID-19.
What Do We Know About Post-COVID-19 Irritable Bowel Syndrome?
Some individuals hospitalized with COVID-19 later develop IBS. Drs Madhusudan Grover and Matthew Hoscheit weigh in on the GI dysfunction.
CDC: Incidence of HIV Continues to Decline, Reaching 32,100 in 2021
Rates of HIV decreased for those aged 13 to 24 years and for infections attributable to male-to-male sexual contact.
Chlamydia Infection: Silent Cause of Female Infertility
Studies link chlamydia to a high risk of female infertility. How should primary care providers assess for inflammation and tubal patency in affected patients?
Physical Activity Affects Flu, Pneumonia Mortality
Aerobic activity, even below recommended level, linked to lower mortality, while J-shaped pattern seen for muscle-strengthening activity.
High HIV Viral Load, Low CD4 Count Impairs Efficacy of First-Line ART
Researchers assessed whether low CD4 count and high HIV viral load increase the risk for treatment failure among treatment-naive patients receiving first-line ART.
HIV Status Affects Changes in BMI, Waist Circumference During Menopause
Researchers assessed the relationship between the transition to menopause and weight gain among women with HIV infection.
Two-Dose Hepatitis A Revaccination Schedule Optimal for Patients With HIV
Researchers evaluated the optimal timing for vasopressin initiation for reducing the risk of mortality among patients with septic shock.
- Loading...
Loading...
Next post in HIV/AIDS Information Center
Loading... 
Loading...